ヒアルロン酸市場：用途別、供給源別、エンドユーザー別、地域別、2026年～2032年

ヒアルロン酸市場の評価、2026年～2032年

アンチエイジングとスキンケア製品の需要を促進する高齢者人口の増加が、ヒアルロン酸の採用を促進しています。皮膚充填剤のような低侵襲の美容施術の人気の高まりは、市場規模を2024年に122億1,000万米ドルを突破し、2032年には約194億4,000万米ドルの評価額に達する原動力となっています。

これに加えて、スキンケアや健康全般に対する消費者の意識の高まりが、ヒアルロン酸の採用に拍車をかけています。有効性と訴求力を高める製剤と送達方法の進歩が、2026年から2032年までのCAGR 6.6%での市場成長を可能にしています。

ヒアルロン酸市場定義／概要

ヒアルロン酸（HA）は、結合組織、皮膚、滑液に見られる天然由来のグリコサミノグリカンです。ヒアルロン酸はグルクロン酸とN-アセチルグルコサミンの二糖単位の繰り返しからなる大きな直鎖多糖です。水分を保持する驚くべき能力で知られるHAは、皮膚の保湿、関節の潤滑、そして組織全体のホメオスタシスの維持に重要な役割を果たしています。高い粘性と生体適合性を含むそのユニークな物理化学的特性により、様々な生物学的および医療的応用において重要な成分となっています。

ヒアルロン酸は、その保湿性と粘弾性特性により、化粧品および医療分野で広く使用されています。皮膚科学と美容学では、HAベースの皮膚充填剤はしわを減らし皮膚にボリュームを与えることで人気があり、顔の若返りのための非外科的選択肢を提供しています。医療では、HAは関節機能を改善し痛みを和らげるために、変形性関節症の関節内補充療法に利用されています。さらに、モイスチャライザーや美容液のようなスキンケア製品の一般的な成分であり、肌の保湿と弾力性を促進します。HAはまた、創傷治癒や眼科学、特に点眼薬や手術用潤滑剤においても役割を果たしています。

ヒアルロン酸の将来の展望は有望であり、現在進行中の研究開発によってその用途は拡大しています。バイオテクノロジーと材料科学の進歩により、HAの生産と機能化が強化され、より効果的で的を絞った治療につながると期待されています。ドラッグデリバリーシステムにおける革新は、治療薬の制御された持続的放出にHAを利用するかもしれないです。

若々しく健康的な肌への欲求の高まりは、どのようにヒアルロン酸の採用を増加させるか？

若々しく健康的な肌への欲求の高まりは、ヒアルロン酸市場の重要な促進要因です。皮膚充填剤のような低侵襲性美容施術の人気は、最小限のダウンタイムでシワを減らし顔のボリュームを増強する効果により急上昇しています。世界人口の高齢化に伴い、アンチエイジング治療への嗜好が高まり、美容・エステティック業界におけるHAベースの製品に対する需要をさらに押し上げています。

これに加えて、変性関節疾患である変形性関節症の有病率は、主に人口の高齢化と肥満率の上昇により、世界的に増加しています。関節痛を和らげ、可動性を改善するために関節内補充療法として用いられるヒアルロン酸注射は、一般的になりつつあります。変形性関節症患者の症状緩和と生活の質の向上におけるHAの有効性が、医療分野におけるHA市場の成長を後押ししています。

また、バイオテクノロジーと医薬品応用における革新が、ヒアルロン酸の範囲を広げています。微生物発酵や組換えDNA技術を含むHA製造の強化された方法は、HA製造の効率とスケーラビリティを向上させました。加えて、HAの生体適合性と非免疫原性により、ドラッグデリバリーシステムと組織工学にとって魅力的な分子となり、先端医療と治療応用における需要を牽引しています。

さらに、スキンケアの重要性に対する意識の高まりと、皮膚の保湿と弾力性の維持におけるヒアルロン酸の利点が、HA市場を牽引しています。消費者は、効果的な保湿とアンチエイジング効果を提供する製品をますます求めるようになっており、保湿剤、美容液、その他のスキンケア処方へのHA配合の急増につながっています。予防的スキンケアへの傾向の高まりと、天然で科学的裏付けのある成分を使った製品への嗜好が、ヒアルロン酸市場の拡大をさらに後押ししています。

ヒアルロン酸に対する認識不足はその応用を抑制するか？

ヒアルロン酸の需要は先進国市場では増加しているが、新興国市場では、可処分所得の低さ、ヒアルロン酸の利点に関する認識不足、高度なヘルスケアおよび化粧品製品の入手可能性の制限などの要因により、その認識と採用は限定的です。従来の安価な代替品もまた、HAベースの製品採用を妨げています。

また、ヒアルロン酸は広く使用され安全であるにもかかわらず、個人によっては副作用やアレルギー反応を引き起こすことがあります。美容用途では、HA注射は赤み、腫れ、あざを引き起こす可能性があり、まれに感染症や肉芽腫形成を伴うケースもあります。このような副作用は、消費者がHAベースの治療を使うことを躊躇させ、市場の成長を抑制する可能性があります。適切な適用技術とリスクに関する教育は、これらの懸念を軽減するのに役立ちます。

これに加えて、ヒアルロン酸（HA）は一般的に安全であるが、特に注入型の場合、発赤、腫脹、あざのような副作用を引き起こす可能性があります。このような懸念は、消費者にHAを用いた治療の使用を思いとどまらせ、訓練を受けた専門家による慎重な投与を必要とするため、コストが増加し、監視のない広範な使用が制限されます。

さらに、ヒアルロン酸の一貫した高品質の供給を確保することは重要な課題です。原料の品質のばらつき、製造工程の違い、汚染リスクは、最終製品の純度と有効性に影響を与える可能性があります。サプライチェーン全体で厳格な品質管理を維持することは不可欠ですが、資源集約的でコストがかかります。品質管理に不備があれば、製品回収、法的問題、ブランド名へのダメージにつながりかねず、市場の成長をさらに抑制することになります。

目次

第1章 ヒアルロン酸市場のイントロダクション

• 市場概要
• 調査範囲
• 前提条件

第2章 エグゼクティブサマリー

第3章 VERIFIED MARKET RESEARCHの調査手法

• データマイニング
• バリデーション
• 一次資料
• データソース一覧

第4章 世界のヒアルロン酸市場展望

• 概要
• 市場力学
  • 促進要因
  • 抑制要因
  • 機会
• ポーターのファイブフォースモデル
• バリューチェーン分析

第5章 ヒアルロン酸の世界市場：用途別

• 概要
• 皮膚フィラー
• 眼科手術
• 変形性関節症治療
• 創傷治癒

第6章 ヒアルロン酸の世界市場：供給源別

• 概要
• 動物由来ヒアルロン酸
• 微生物発酵

第7章 ヒアルロン酸の世界市場：エンドユーザー別

• 概要
• 化粧品とパーソナルケア
• 医療・ヘルスケア
• 栄養補助食品と栄養補助食品

第8章 ヒアルロン酸の世界市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • その他欧州
• アジア太平洋
  • 中国
  • 日本
  • インド
  • その他アジア太平洋地域
• 世界のその他の地域
  • ラテンアメリカ
  • 中東・アフリカ

第9章 世界のヒアルロン酸市場の競合情勢

• 概要
• 各社の市場ランキング
• 主な発展戦略

第10章 企業プロファイル

• Anika Therapeutics
• Allergan plc
• Galderma
• Ferring Pharmaceuticals
• Fidia Farmaceutici
• Merz Pharma
• Seikagaku Corporation
• Sanofi
• Zimmer Biomet Holdings
• Smith & Nephew plc

第11章 付録

• 関連調査

Hyaluronic Acid Market Valuation - 2026-2032

Increasing elderly population driving demand for anti-aging and skincare products is propelling the adoption of Hyaluronic Acid. Rising popularity of minimally invasive cosmetic procedures like dermal fillers is driving the market size surpass USD 12.21 Billion valued in 2024 to reach a valuation of around USD 19.44 Billion by 2032.

In addition to this, growing consumer awareness about skincare and overall health benefits is spurring up the adoption of Hyaluronic Acid. Advancements in formulations and delivery methods enhancing effectiveness and appeal is enabling the market grow at a CAGR of 6.6% from 2026 to 2032.

Hyaluronic Acid Market: Definition/ Overview

Hyaluronic acid (HA) is a naturally occurring glycosaminoglycan found in connective tissues, skin, and synovial fluid. It is a large, linear polysaccharide composed of repeating disaccharide units of glucuronic acid and N-acetylglucosamine. Known for its remarkable ability to retain water, HA plays a crucial role in maintaining skin hydration, joint lubrication, and overall tissue homeostasis. Its unique physicochemical properties, including high viscosity and biocompatibility, make it a key component in various biological and medical applications.

Hyaluronic acid is widely used in the cosmetic and medical fields due to its hydrating and viscoelastic properties. In dermatology and aesthetics, HA-based dermal fillers are popular for reducing wrinkles and adding volume to the skin, providing a non-surgical option for facial rejuvenation. In medicine, HA is utilized in viscosupplementation treatments for osteoarthritis to improve joint function and relieve pain. Additionally, it is a common ingredient in skincare products like moisturizers and serums, promoting skin hydration and elasticity. HA also plays a role in wound healing and ophthalmology, particularly in eye drops and surgical lubricants.

The future scope of hyaluronic acid is promising, with ongoing research and development expanding its applications. Advances in biotechnology and materials science are expected to enhance the production and functionalization of HA, leading to more effective and targeted therapies. Innovations in drug delivery systems may utilize HA for controlled and sustained release of therapeutics.

How will Rising Desire for Youthful and Healthy-Looking Skin Increase Adoption of Hyaluronic Acid?

The growing desire for youthful and healthy-looking skin is a significant driver of the Hyaluronic Acid Market. The popularity of minimally invasive cosmetic procedures, such as dermal fillers, has surged due to their effectiveness in reducing wrinkles and enhancing facial volume with minimal downtime. As the global population ages, there is an increasing preference for anti-aging treatments, further boosting the demand for HA-based products in the beauty and aesthetics industry.

In addition to this, the prevalence of osteoarthritis, a degenerative joint disease, is increasing globally, primarily due to the aging population and rising obesity rates. Hyaluronic acid injections, used as a viscosupplementation treatment to relieve joint pain and improve mobility, are becoming more common. The effectiveness of HA in providing symptomatic relief and improving the quality of life for osteoarthritis patients is driving the growth of the HA market in the medical field.

Also, innovations in biotechnology and pharmaceutical applications are expanding the scope of hyaluronic acid. Enhanced methods of HA production, including microbial fermentation and recombinant DNA technology, have improved the efficiency and scalability of HA manufacturing. Additionally, HA's biocompatibility and non-immunogenic nature make it an attractive molecule for drug delivery systems and tissue engineering, driving its demand in advanced medical and therapeutic applications.

Furthermore, the rising awareness of the importance of skincare and the benefits of hyaluronic acid in maintaining skin hydration and elasticity are driving the HA market. Consumers are increasingly seeking products that offer effective hydration and anti-aging benefits, leading to a surge in the inclusion of HA in moisturizers, serums, and other skincare formulations. The growing trend towards preventive skincare and the preference for products with natural and scientifically-backed ingredients further support the expansion of the Hyaluronic Acid Market.

Will Lack of Awareness about Hyaluronic Acid Restrain Its Application?

Hyaluronic acid demand is increasing in developed markets, but in developing regions, awareness and adoption are limited due to factors like lower disposable incomes, lack of awareness about its benefits, and limited availability of advanced healthcare and cosmetic products. Traditional and less expensive alternatives also hinder HA-based product adoption.

Also, hyaluronic acid, despite its widespread use and safety, can cause side effects and allergic reactions in some individuals. In cosmetic applications, HA injections can cause redness, swelling, and bruising, with rare cases involving infections or granuloma formation. These adverse effects can deter consumers from using HA-based treatments, restraining market growth. Proper application techniques and education about risks can help mitigate these concerns.

In addition to this, hyaluronic acid (HA) is generally safe but can cause side effects like redness, swelling, and bruising, especially in injectable forms. These concerns discourage consumers from using HA-based treatments and require careful administration by trained professionals, increasing costs and limiting widespread, unsupervised use.

Furthermore, ensuring a consistent and high-quality supply of hyaluronic acid is a significant challenge. Variations in raw material quality, differences in production processes, and contamination risks can impact the final product's purity and effectiveness. Maintaining stringent quality control across the supply chain is essential but can be resource-intensive and costly. Any lapses in quality control can lead to product recalls, legal issues, and damage to brand reputation, further restraining market growth.

Category-Wise Acumens

Will Rise in Adoption of Animal-Derived Hyaluronic Acid Drive Hyaluronic Acid Market?

Animal-derived hyaluronic acid (HA) remains the dominant market due to its long-standing history and efficacy, particularly from rooster combs. Manufacturers and end-users prefer this HA due to its proven track record and natural origin, often associated with higher efficacy in medical applications like eye surgeries and joint treatments.

Also, this type of hyaluronic acid benefits from well-established manufacturing processes and regulatory approvals that have been in place for decades. These processes have been refined over time, ensuring a reliable and consistent quality of HA suitable for various medical and cosmetic applications. In certain therapeutic areas, such as ophthalmology and orthopedics, the specific properties of animal-derived HA, including its molecular weight and structure, are preferred for their effectiveness in treatments. This entrenched preference supports the continued dominance of animal-derived HA in these applications.

In addition to this, consumer perception plays a significant role in the dominance of animal-derived hyaluronic acid. Many consumers and healthcare providers associate animal-derived products with a higher degree of naturalness and effectiveness, particularly in therapeutic settings. Additionally, certain regulatory environments and market segments are more familiar and comfortable with animal-derived HA, further bolstering its market position. Despite the rise of microbial fermentation methods, the entrenched market presence, combined with the specific benefits attributed to animal-derived HA, ensures its continued dominance in key segments of the Hyaluronic Acid Market.

Which Factors Enhance the Use of Hyaluronic Acid in Cosmetics and Personal Care?

The cosmetics and personal care segment dominates the Hyaluronic Acid Market due to its extensive application in various skincare products. HA is highly valued for its exceptional hydrating properties, which help retain moisture in the skin, enhance elasticity, and reduce the appearance of fine lines and wrinkles. This makes it a key ingredient in moisturizers, serums, anti-aging creams, and facial masks. The ongoing demand for effective and innovative skincare solutions ensures that HA remains a staple in the beauty industry, driving its market dominance.

In addition to this, continuous innovation and product development in the beauty industry also play a crucial role in the dominance of hyaluronic acid in the cosmetics and personal care segment. Companies are constantly researching and formulating new HA-based products to meet the diverse needs of consumers. These innovations include various molecular weights of HA for deeper skin penetration, combining HA with other active ingredients for enhanced efficacy, and developing advanced delivery systems. This relentless pursuit of innovation not only keeps HA at the forefront of skincare trends but also reinforces its position as a leading ingredient in the market.

Furthermore, the trend towards sustainable and natural skincare products has also benefited the Hyaluronic Acid Market. Consumers are increasingly looking for ingredients that are not only effective but also safe and environmentally friendly. Hyaluronic acid, especially when derived from non-animal sources through microbial fermentation, aligns well with this trend. Brands that emphasize clean beauty and sustainability often highlight HA in their formulations, appealing to eco-conscious consumers. This alignment with consumer values ensures that hyaluronic acid continues to be a preferred ingredient in the cosmetics and personal care market, securing its long-term dominance.

Country/Region-wise Acumens

Will Well-Established Culture of Skincare Consciousness in North America Mature Hyaluronic Acid Market?

North America stands at the forefront of the Hyaluronic Acid Market, driven by robust consumer demand and a flourishing skincare industry. The region boasts a well-established culture of skincare consciousness, with consumers actively seeking innovative products to address aging concerns and maintain skin health. Hyaluronic acid's exceptional hydrating properties and anti-aging benefits have made it a staple ingredient in numerous skincare formulations, ranging from moisturizers to serums and masks.

Also, leading pharmaceutical and cosmetic companies headquartered in North America play a pivotal role in driving market growth. These companies leverage their research and development capabilities to innovate new formulations and products containing hyaluronic acid. Moreover, partnerships with dermatologists, plastic surgeons, and aesthetic practitioners help promote HA-based treatments and products, enhancing their accessibility and popularity among consumers.

In addition to this, the region's high disposable incomes and consumer purchasing power contribute significantly to the dominance of hyaluronic acid in North America. Consumers are willing to invest in premium skincare products and aesthetic treatments that offer visible results and long-term benefits. This willingness to spend on skincare and beauty contributes to the sustained demand for HA-based products, driving market growth and reinforcing North America's position as a global leader in the Hyaluronic Acid Market.

Will Booming Skincare Industry Enhance Adoption of Hyaluronic Acid in Asia Pacific?

The Asia Pacific region is witnessing remarkable growth in the Hyaluronic Acid Market, largely driven by the booming skincare industry. Countries like South Korea, Japan, and China are leading the charge, with a strong cultural emphasis on skincare and beauty. The region's skincare market is expanding rapidly, fueled by increasing consumer awareness and demand for products that offer hydration, anti-aging, and overall skin health. Hyaluronic acid, renowned for its hydrating properties, is a key ingredient in many skincare formulations, driving its rapid adoption and market growth.

In addition to this, Asia Pacific is at the forefront of innovative beauty trends, with a particular focus on K-beauty (Korean beauty) and J-beauty (Japanese beauty) influences. These beauty philosophies emphasize a holistic approach to skincare, incorporating multiple steps and high-quality ingredients like hyaluronic acid. The popularity of K-beauty skincare routines, known for their efficacy in achieving radiant and youthful skin, has spurred the demand for HA-based products across the region. As consumers increasingly seek out innovative beauty solutions, the market for hyaluronic acid continues to expand rapidly.

Furthermore, the Asia Pacific region is witnessing a surge in demand for aesthetic procedures, including non-invasive treatments and cosmetic surgeries. Countries like South Korea, known as a global hub for cosmetic procedures, see high demand for hyaluronic acid fillers and other injectable treatments for facial rejuvenation. With a growing number of individuals seeking to enhance their appearance and address skincare concerns, the demand for HA-based aesthetic procedures is skyrocketing, contributing to the rapid growth of the market in Asia Pacific.

Also, the influence of social media platforms and beauty influencers is pervasive in the Asia Pacific region, shaping consumer preferences and driving product trends. Beauty bloggers and influencers play a significant role in promoting skincare products, including those containing hyaluronic acid, to their followers. As social media platforms continue to serve as a platform for beauty education and product recommendations, the demand for HA-based skincare products is likely to continue rising, contributing to the rapid growth of the market in Asia Pacific.

Competitive Landscape

In the competitive landscape of the Hyaluronic Acid Market, numerous companies vie for market share, each striving to differentiate themselves through product innovation, quality, and strategic partnerships. With a focus on expanding their product portfolios and enhancing production capabilities, companies invest in research and development to develop novel formulations and delivery systems for hyaluronic acid. Furthermore, collaborations with healthcare professionals and dermatologists aid in promoting the benefits of HA-based treatments and products, while regulatory compliance ensures product safety and efficacy. As consumer demand for skincare and medical solutions containing hyaluronic acid continues to grow, companies in the market are poised to capitalize on emerging opportunities and gain a competitive edge in the dynamic landscape. Some of the prominent players operating in the Hyaluronic Acid Market include:

Anika Therapeutics, Allergan plc, Galderma, Ferring Pharmaceuticals, Fidia Farmaceutici, Merz Pharma, Seikagaku Corporation, Sanofi, Zimmer Biomet Holdings, Smith & Nephew plc, Contura International, LG Chem, Bohus BioTech AB, Shanghai Haohai Biological Technology, Hangzhou Biotech, Bloomage BioTechnology, Lifecore Biomedical, Salix Pharmaceuticals, Shiseido, Genzyme Biosurgery.

Latest Developments

In June 2023, Galderma received FDA approval for Restylane EyeLight, a treatment for undereye dullens, or black shadows, in adults aged 21 and older.

In May 2023, Allergan Aesthetics received US FDA approval for its 'Skinvive' product, a hyaluronic acid intradermal microdroplet injection.

In January 2022, Seikagaku Corporation established Seikagaku North America Corporation in Canada as a wholly owned subsidiary of Dalton Chemical Laboratories.

In August 2022, Allergan Aesthetics received FDA clearance for JUVEDERM VOLUX XC, a product designed to improve jaw contour in adults aged 21 and above with moderate to severe jaw contour loss.

Hyaluronic Acid Market, By Category

• Application:
• Dermal Fillers
• Ophthalmic Surgery
• Osteoarthritis Treatment
• Wound Healing
• Source:
• Animal-derived Hyaluronic Acid
• Microbial Fermentation
• End-Users:
• Cosmetics and Personal Care
• Medical and Healthcare
• Nutraceuticals and Dietary Supplements
• Region:
• North America
• Europe
• Asia-Pacific
• South America
• Middle East & Africa

TABLE OF CONTENTS

1 INTRODUCTION OF HYALURONIC ACID MARKET

• 1.1 Overview of the Market
• 1.2 Scope of Report
• 1.3 Assumptions

2 EXECUTIVE SUMMARY

3 RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH

• 3.1 Data Mining
• 3.2 Validation
• 3.3 Primary Interviews
• 3.4 List of Data Sources

4 GLOBAL HYALURONIC ACID MARKET OUTLOOK

• 4.1 Overview
• 4.2 Market Dynamics
  • 4.2.1 Drivers
  • 4.2.2 Restraints
  • 4.2.3 Opportunities
• 4.3 Porters Five Force Model
• 4.4 Value Chain Analysis

5 GLOBAL HYALURONIC ACID MARKET, BY APPLICATION

• 5.1 Overview
• 5.2 Dermal Fillers
• 5.3 Ophthalmic Surgery
• 5.4 Osteoarthritis Treatment
• 5.5 Wound Healing

6 GLOBAL HYALURONIC ACID MARKET, BY SOURCE

• 6.1 Overview
• 6.2 Animal-derived Hyaluronic Acid
• 6.3 Microbial Fermentation

7 GLOBAL HYALURONIC ACID MARKET, BY END-USERS

• 7.1 Overview
• 7.2 Cosmetics and Personal Care
• 7.3 Medical and Healthcare
• 7.4 Nutraceuticals and Dietary Supplements

8 GLOBAL HYALURONIC ACID MARKET, BY GEOGRAPHY

• 8.1 Overview
• 8.2 North America
  • 8.2.1 U.S.
  • 8.2.2 Canada
  • 8.2.3 Mexico
• 8.3 Europe
  • 8.3.1 Germany
  • 8.3.2 U.K.
  • 8.3.3 France
  • 8.3.4 Rest of Europe
• 8.4 Asia Pacific
  • 8.4.1 China
  • 8.4.2 Japan
  • 8.4.3 India
  • 8.4.4 Rest of Asia Pacific
• 8.5 Rest of the World
  • 8.5.1 Latin America
  • 8.5.2 Middle East and Africa

9 GLOBAL HYALURONIC ACID MARKET COMPETITIVE LANDSCAPE

• 9.1 Overview
• 9.2 Company Market Ranking
• 9.3 Key Development Strategies

10 COMPANY PROFILES

• 10.1 Anika Therapeutics
  • 10.1.1 Overview
  • 10.1.2 Financial Performance
  • 10.1.3 Product Outlook
  • 10.1.4 Key Developments
• 10.2 Allergan plc
  • 10.2.1 Overview
  • 10.2.2 Financial Performance
  • 10.2.3 Product Outlook
  • 10.2.4 Key Developments
• 10.3 Galderma
  • 10.3.1 Overview
  • 10.3.2 Financial Performance
  • 10.3.3 Product Outlook
  • 10.3.4 Key Developments
• 10.4 Ferring Pharmaceuticals
  • 10.4.1 Overview
  • 10.4.2 Financial Performance
  • 10.4.3 Product Outlook
  • 10.4.4 Key Developments
• 10.5 Fidia Farmaceutici
  • 10.5.1 Overview
  • 10.5.2 Financial Performance
  • 10.5.3 Product Outlook
  • 10.5.4 Key Developments
• 10.6 Merz Pharma
  • 10.6.1 Overview
  • 10.6.2 Financial Performance
  • 10.6.3 Product Outlook
  • 10.6.4 Key Developments
• 10.7 Seikagaku Corporation
  • 10.7.1 Overview
  • 10.7.2 Financial Performance
  • 10.7.3 Product Outlook
  • 10.7.4 Key Developments
• 10.8 Sanofi
  • 10.8.1 Overview
  • 10.8.2 Financial Performance
  • 10.8.3 Product Outlook
  • 10.8.4 Key Developments
• 10.9 Zimmer Biomet Holdings
  • 10.9.1 Overview
  • 10.9.2 Financial Performance
  • 10.9.3 Product Outlook
  • 10.9.4 Key Developments
• 10.10 Smith & Nephew plc
  • 10.10.1 Overview
  • 10.10.2 Financial Performance
  • 10.10.3 Product Outlook
  • 10.10.4 Key Developments

11 Appendix

• 11.1 Related Research